Alendronate Sodium Tablet
Product Images NDC 50090-4692

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 50090-4692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 01

Chemical structure of alendronate sodium, showing the molecular arrangement with amino, phosphate, and sodium groups including three water molecules of hydration (3H2O).*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 02

A line graph showing the cumulative incidence of hip fractures over 36 months in a three-year study of patients with vertebral fractures. The graph compares placebo (dashed line) and alendronate sodium (solid line) groups, with cumulative incidence (%) on the vertical axis and time (months) on the horizontal axis.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 03

A bar chart titled 'Osteoporosis Treatment Studies in Postmenopausal Women: Increase in BMD with Alendronate Sodium 10 mg/day at Three Years.' It compares mean percent increase in bone mineral density (BMD) relative to placebo plus standard error for three anatomical sites—lumbar spine, femoral neck, and trochanter—in U.S. and multinational populations.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 04

Two line graphs titled 'Osteoporosis Treatment Studies in Postmenopausal women' showing the time course of effect of Alendronate Sodium 10 mg/day versus placebo on lumbar spine BMD percent change from baseline. The left graph represents a US study and the right a multinational study, both plotting mean percentage change in BMD from baseline over 36 months. Alendronate Sodium shows an increasing positive change, while placebo remains near baseline.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 05

Two bar graphs titled 'Osteoporosis Prevention Studies in Postmenopausal Women' depicting change in bone mineral density (BMD) from baseline over 2-year and 3-year studies. Each graph compares mean percentage BMD change ± SE in lumbar spine, femoral neck, trochanter, and total body for Alendronate Sodium 5 mg/day versus placebo groups.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 06

Bar chart titled 'Studies in Glucocorticoid - Treated Patients Increase in BMD Alendronate Sodium 5 mg/day at One Year.' It compares mean percent increase in bone mineral density (BMD) relative to placebo at lumbar spine, femoral neck, and trochanter sites between U.S. and multinational study groups, with error bars showing standard error.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 07

A line graph showing the effect on serum alkaline phosphatase levels over six months in patients with Paget's Disease of Bone. The graph compares Alendronate Sodium 40 mg/day from multinational and U.S. studies, Etidronate 400 mg/day, and placebo. The y-axis represents the mean percentage change from baseline, and the x-axis represents time in months.*

FDA Label Image

Label Image (Lbl500904692)

Label for ALENDRONATE SODIUM 70 mg oral tablets by A-S Medication Solutions. The label includes dosage information, storage instructions to keep tablets at 68 to 77 degrees Fahrenheit, and packaging details indicating 1 blister containing 4 tablets. The label also displays the product NDC 50090-4692-0 and mentions the strength as 70 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.